In his new role, Julian Schink, MD, will provide leadership and direction for CTCA clinical programs. He also will serve as a liaison between physicians and administrative leaders.“I am excited to take on this new challenge,” says Dr. Schink. “I’m thrilled to work with my talented colleagues across the enterprise and am laser-focused on the opportunities we have to expand access to innovative treatment options and compassionate care for patients across the U.S. and internationally.”
